WHITEHAWK THERAPEUTICS, INC. Foreign Currency Transaction Gain (Loss), before Tax
WHITEHAWK THERAPEUTICS, INC. (WHWK) reported Foreign Currency Transaction Gain (Loss), before Tax of -$6.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Other Income
us-gaap:ForeignCurrencyTransactionGainLossBeforeTax · last filed 2026-08-06
- WHITEHAWK THERAPEUTICS, INC. foreign currency transaction gain (loss), before tax for the quarter ending 2026-06-30 was -$6.00K.
- WHITEHAWK THERAPEUTICS, INC. foreign currency transaction gain (loss), before tax for the quarter ending 2025-12-31 was $8.00K.
- WHITEHAWK THERAPEUTICS, INC. foreign currency transaction gain (loss), before tax for the quarter ending 2025-09-30 was $0.00.
- WHITEHAWK THERAPEUTICS, INC. foreign currency transaction gain (loss), before tax for the quarter ending 2025-06-30 was -$3.00K.
- WHITEHAWK THERAPEUTICS, INC. foreign currency transaction gain (loss), before tax for fiscal 2025 was $5.00K.
- WHITEHAWK THERAPEUTICS, INC. foreign currency transaction gain (loss), before tax for fiscal 2024 was -$4.00K.
- WHITEHAWK THERAPEUTICS, INC. foreign currency transaction gain (loss), before tax for fiscal 2023 was -$1.00K.
- WHITEHAWK THERAPEUTICS, INC. foreign currency transaction gain (loss), before tax for fiscal 2022 was $0.00.
| Period end | Foreign Currency Transaction Gain (Loss), before Tax 3 month | Foreign Currency Transaction Gain (Loss), before Tax 6 month | Foreign Currency Transaction Gain (Loss), before Tax 9 month | Foreign Currency Transaction Gain (Loss), before Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$6.00K 10-Q · filed 2026-08-06 | -$6.00K 10-Q · filed 2026-08-06 | ||
| 2025-12-31 | $8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $8.00K derived: sum of 2 quarters · filed 2026-03-12 | $5.00K derived: sum of 3 quarters · filed 2026-08-06 | $5.00K 10-K · filed 2026-03-12 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-06 | -$3.00K derived: sum of 2 quarters · filed 2026-08-06 | -$3.00K 10-Q · filed 2025-11-06 | -$3.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$3.00K 10-Q · filed 2026-08-06 | -$3.00K 10-Q · filed 2026-08-06 | -$3.00K derived: sum of 3 quarters · filed 2026-08-06 | -$4.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-08 | $0.00 derived: sum of 2 quarters · filed 2026-03-12 | -$1.00K derived: sum of 3 quarters · filed 2026-03-12 | -$3.00K derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$1.00K derived: sum of 2 quarters · filed 2026-03-12 | -$3.00K derived: sum of 3 quarters · filed 2026-03-12 | -$4.00K 10-K · filed 2026-03-12 |
| 2024-09-30 | -$1.00K 10-Q · filed 2025-11-06 | -$3.00K derived: sum of 2 quarters · filed 2025-11-06 | -$4.00K 10-Q · filed 2025-11-06 | -$2.00K derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | -$2.00K 10-Q · filed 2025-08-07 | -$3.00K 10-Q · filed 2025-08-07 | -$1.00K derived: sum of 3 quarters · filed 2025-08-07 | -$1.00K derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | -$1.00K 10-Q · filed 2025-05-08 | $1.00K derived: sum of 2 quarters · filed 2025-05-08 | $1.00K derived: sum of 3 quarters · filed 2025-05-08 | -$2.00K derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $2.00K derived: sum of 2 quarters · filed 2025-03-28 | -$1.00K derived: sum of 3 quarters · filed 2025-03-28 | -$1.00K 10-K · filed 2025-03-28 |
| 2023-09-30 | $0.00 10-Q · filed 2024-11-06 | -$3.00K derived: sum of 2 quarters · filed 2024-11-06 | -$3.00K 10-Q · filed 2024-11-06 | -$3.00K derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | -$3.00K 10-Q · filed 2024-08-07 | -$3.00K 10-Q · filed 2024-08-07 | -$3.00K derived: sum of 3 quarters · filed 2024-08-07 | -$3.00K derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-08 | $0.00 derived: sum of 2 quarters · filed 2024-05-08 | $0.00 derived: sum of 3 quarters · filed 2024-05-08 | $0.00 derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $0.00 derived: sum of 2 quarters · filed 2024-03-13 | $0.00 derived: sum of 3 quarters · filed 2024-03-13 | $0.00 10-K · filed 2024-03-13 |
| 2022-09-30 | $0.00 10-Q · filed 2023-11-08 | $0.00 derived: sum of 2 quarters · filed 2023-11-08 | $0.00 10-Q · filed 2023-11-08 | |
| 2022-06-30 | $0.00 10-Q · filed 2023-08-09 | $0.00 10-Q · filed 2023-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |